Clinical Trials on Immune System Support in Australia

Total 6715 results

Medical University of Vienna

Completed

Evaluation of Platelet Therapy Response in Left Ventricular Assist Device Patients

Cardiomyopathies | End-stage Heart Failure | Mechanical Circulatory Support

Austria
St. Pölten University of Applied Sciences
Karl Landsteiner University of Health Sciences; Austrian Health Insurance Fund

Active, not recruiting

Improving Glycaemic Control in Patients With Type 2 Diabetes Mellitus Through Peer Support Instant Messaging (DiabPeerS)

Diabetes Mellitus, Type 2 | Peer Support | Instant Messaging Service

Austria
Thomas Schlöglhofer
Abbott; German Heart Center

Recruiting

Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps (HM3_Snoopy)

Cardiomyopathies | End-stage Heart Failure | Mechanical Circulatory Support

Austria
SinoMab BioScience Ltd

Unknown

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject

Autoimmune Diseases

Australia
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (ReNew)

Multiple Sclerosis

Australia
Sinocelltech Ltd.

Not yet recruiting

Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers

Autoimmune Disease

Australia
Innocare Pharma Australia Pty Ltd

Completed

A Phase I Study of ICP-022 in Healthy Subjects

Rheumatoid Arthritis | Systemic Lupus Erythematosus

Australia
The Canberra Hospital

Completed

Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy

Colonic Diseases

Australia
CSL Limited

Completed

Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

Primary Immune Deficiency (PID)

Australia
CSL Limited

Completed

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP)

Australia
Kirby Institute
Government of Western Australia, Department of Health; Western Australia AIDS...

Completed

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial (PrEPIT-WA)

HIV Prevention

Australia
Bayside Health

Completed

Efficacy Study of Outpatient Therapy for Lymphoma

Non-Hodgkin's Lymphoma | Hodgkin's Disease

Australia
Connect Biopharma Australia Pty Ltd

Completed

A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects

Autoimmune Diseases

Australia, United States
Trans Tasman Radiation Oncology Group
Australasian Leukaemia and Lymphoma Group

Completed

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Primary Central Nervous System Lymphoma

Australia, New Zealand
KoBioLabs
Novotech (Australia) Pty Limited

Completed

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Moderate to Severe Asthma

Australia
Vyne Therapeutics Inc.

Completed

Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Australia
Shanghai Medinno Pharmaceutical Technology Co.,...

Recruiting

A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults

Allergic Conjunctivitis

Australia
Pipeline Therapeutics, Inc.

Completed

Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers

Multiple Sclerosis

Australia
Bayside Health
Monash University; Austin Health; Rockefeller University; The Peter Doherty Institute... and other collaborators

Completed

Imaging the HIV Reservoir

HIV

Australia
Suzhou Connect Biopharmaceuticals, Ltd.
Tigermed Consulting Co., Ltd; Nucleus Network Ltd

Completed

Phase 1 Study Accessing the Safety and Tolerability of CBP-307

Autoimmune Diseases

Australia
Medical University Innsbruck
Institute of Mountain Emergency Medicine

Active, not recruiting

A 13-years Nationwide Study of Alpine Accidents in Austria

Climbing | Alpine Accident | Sleighing | Cycling | Canyoning | Hiking | Snowshoeing | Alpine Water-sport | Skiing/Snowboarding

Austria
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
Pfenex, Inc

Completed

Comparison Study of PF530 and Betaferon in Healthy Subjects

Multiple Sclerosis

Australia
Incannex Healthcare Ltd

Recruiting

Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (CHAPPII)

Rheumatoid Arthritis

Australia
Tunitas Therapeutics, Inc.
Tunitas Therapeutics Australia Pty Ltd

Terminated

Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects

Allergy and Immunology

Australia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

Leukemia

Australia
De Motu Cordis
Novotech (Australia) Pty Limited

Not yet recruiting

Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Anaphylactic Reaction

Australia
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN); Tunitas Therapeutics, Inc.

Terminated

Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy

Cat Allergy

Australia
Central Adelaide Local Health Network Incorporated
Vaxine Pty Ltd

Unknown

Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax) (Jumpvax)

Immunotherapy | Ant Sting

Australia
University of Melbourne
The Alfred; ViiV Healthcare

Completed

Dolutegravir Impact on Residual Replication (DIORR)

HIV

Australia
Janssen-Cilag Pty Ltd

Completed

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

HIV-1

Australia
R.P.Herrmann
Royal Perth Hospital

Unknown

Mesenchymal Stromal Cells for Acute Graft Versus Host Disease

Acute GVH Disease

Australia
Athos Therapeutics Inc
Syneos Health; Athos Therapeutics Australia Pty Ltd

Recruiting

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Autoimmune Diseases | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Australia
NImmune Biopharma

Completed

Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers

Normal Healthy Volunteers

Australia
CSL Limited

Completed

Subcutaneous Ig NextGen 16% in PID Patients

Primary Immunodeficiency (PID)

Australia, New Zealand
Moleac Pte Ltd.
Moleac Australia Pty Ltd

Completed

Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects

Stroke

Australia
Murdoch Childrens Research Institute

Not yet recruiting

Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy (HILO)

Peanut Allergy

Australia
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

HIV

United Kingdom, Germany, Denmark, Belgium, Austria, Poland, Australia, Russian Federation
GlaxoSmithKline

Completed

Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers (P1A114347)

Multiple Sclerosis, Relapsing-Remitting

Australia
Atridia Pty Ltd.

Completed

A Trial of SHR-1905 in Healthy Subjects

Asthma

Australia
Holdsworth House Medical Practice
Gilead Sciences

Completed

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia (RiC)

HIV

Australia
Holdsworth House Medical Practice
Bristol-Myers Squibb

Completed

Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia (REfLecT)

HIV

Australia
Holdsworth House Medical Practice
Gilead Sciences

Completed

Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia

HIV

Australia
Atridia Pty Ltd.

Terminated

A Trial of SHR-1703 in Healthy Subjects

Asthma

Australia
The Queen Elizabeth Hospital

Completed

Smoking Termination Opportunity for inPatients (STOP)

Tobacco Use Disorder

Australia
Solarea Bio, Inc

Recruiting

SBD121, a Synbiotic Medical Food for RA Management

Rheumatoid Arthritis

Australia, New Zealand
Bayside Health
The Peter Doherty Institute for Infection and Immunity

Recruiting

Optimising Cohorts for HIV Cure Interventions (HI-ART)

HIV-1-infection

Australia
University of Melbourne
Johns Hopkins University; Oregon Health and Science University; University of... and other collaborators

Completed

HIV Persistence in Lymph Node and Peripheral Blood (HIV-PRADA)

HIV-1-infection

Australia
Presage Biosciences
Takeda

Withdrawn

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Solid Tumour

Australia
University of Sydney
The Albion Centre - South Eastern Sydney Local Health District

Unknown

Using Implementation Intentions to Increase Safe Sex Practices in MSM

HIV | Sex

Australia

Clinical Trials on Immune System Support in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations